img

Global siRNA Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global siRNA Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

siRNA Drugs report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global siRNA Drugs market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Genetic Disease and Cancers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for siRNA Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, siRNA Drugs key companies include Alnylam, Novartis, Sirnaomics and Ribo Life Science, etc. Alnylam, Novartis, Sirnaomics are top 3 players and held % share in total in 2023.
siRNA Drugs can be divided into Without GalNAc-conjugated and With GalNAc-conjugated, etc. Without GalNAc-conjugated is the mainstream product in the market, accounting for % share globally in 2023.
siRNA Drugs is widely used in various fields, such as Genetic Disease, Cancers and Other,, etc. Genetic Disease provides greatest supports to the siRNA Drugs industry development. In 2023, global % share of siRNA Drugs went into Genetic Disease filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global siRNA Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Alnylam
Novartis
Sirnaomics
Ribo Life Science
Segment by Type
Without GalNAc-conjugated
With GalNAc-conjugated

Segment by Application


Genetic Disease
Cancers
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the siRNA Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, siRNA Drugs introduction, etc. siRNA Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of siRNA Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Market Overview of siRNA Drugs
1.1 siRNA Drugs Market Overview
1.1.1 siRNA Drugs Product Scope
1.1.2 siRNA Drugs Market Status and Outlook
1.2 Global siRNA Drugs Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global siRNA Drugs Market Size by Region (2018-2033)
1.4 Global siRNA Drugs Historic Market Size by Region (2018-2023)
1.5 Global siRNA Drugs Market Size Forecast by Region (2024-2033)
1.6 Key Regions, siRNA Drugs Market Size (2018-2033)
1.6.1 North America siRNA Drugs Market Size (2018-2033)
1.6.2 Europe siRNA Drugs Market Size (2018-2033)
1.6.3 Asia-Pacific siRNA Drugs Market Size (2018-2033)
1.6.4 Latin America siRNA Drugs Market Size (2018-2033)
1.6.5 Middle East & Africa siRNA Drugs Market Size (2018-2033)
2 siRNA Drugs Market by Type
2.1 Introduction
2.1.1 Without GalNAc-conjugated
2.1.2 With GalNAc-conjugated
2.2 Global siRNA Drugs Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global siRNA Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global siRNA Drugs Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America siRNA Drugs Revenue Breakdown by Type (2018-2033)
2.3.2 Europe siRNA Drugs Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific siRNA Drugs Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America siRNA Drugs Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa siRNA Drugs Revenue Breakdown by Type (2018-2033)
3 siRNA Drugs Market Overview by Application
3.1 Introduction
3.1.1 Genetic Disease
3.1.2 Cancers
3.1.3 Other
3.2 Global siRNA Drugs Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global siRNA Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global siRNA Drugs Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America siRNA Drugs Revenue Breakdown by Application (2018-2033)
3.3.2 Europe siRNA Drugs Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific siRNA Drugs Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America siRNA Drugs Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa siRNA Drugs Revenue Breakdown by Application (2018-2033)
4 siRNA Drugs Competition Analysis by Players
4.1 Global siRNA Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in siRNA Drugs as of 2023)
4.3 Date of Key Players Enter into siRNA Drugs Market
4.4 Global Top Players siRNA Drugs Headquarters and Area Served
4.5 Key Players siRNA Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 siRNA Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alnylam
5.1.1 Alnylam Profile
5.1.2 Alnylam Main Business
5.1.3 Alnylam siRNA Drugs Products, Services and Solutions
5.1.4 Alnylam siRNA Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Alnylam Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis siRNA Drugs Products, Services and Solutions
5.2.4 Novartis siRNA Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Sirnaomics
5.3.1 Sirnaomics Profile
5.3.2 Sirnaomics Main Business
5.3.3 Sirnaomics siRNA Drugs Products, Services and Solutions
5.3.4 Sirnaomics siRNA Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Ribo Life Science Recent Developments
5.4 Ribo Life Science
5.4.1 Ribo Life Science Profile
5.4.2 Ribo Life Science Main Business
5.4.3 Ribo Life Science siRNA Drugs Products, Services and Solutions
5.4.4 Ribo Life Science siRNA Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Ribo Life Science Recent Developments
6 North America
6.1 North America siRNA Drugs Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe siRNA Drugs Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific siRNA Drugs Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America siRNA Drugs Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa siRNA Drugs Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 siRNA Drugs Market Dynamics
11.1 siRNA Drugs Industry Trends
11.2 siRNA Drugs Market Drivers
11.3 siRNA Drugs Market Challenges
11.4 siRNA Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market siRNA Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global siRNA Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global siRNA Drugs Market Size Share by Region (2018-2023)
Table 4. Global siRNA Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global siRNA Drugs Forecasted Market Size Share by Region (2024-2033)
Table 6. Global siRNA Drugs Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global siRNA Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global siRNA Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global siRNA Drugs Revenue Market Share by Type (2024-2033)
Table 11. North America siRNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America siRNA Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe siRNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe siRNA Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific siRNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific siRNA Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America siRNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America siRNA Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa siRNA Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa siRNA Drugs Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global siRNA Drugs Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global siRNA Drugs Revenue Market Share by Application (2018-2023)
Table 24. Global siRNA Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global siRNA Drugs Revenue Market Share by Application (2024-2033)
Table 26. North America siRNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America siRNA Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe siRNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe siRNA Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific siRNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific siRNA Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America siRNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America siRNA Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa siRNA Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa siRNA Drugs Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global siRNA Drugs Revenue (US$ Million) by Players (2018-2023)
Table 37. Global siRNA Drugs Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in siRNA Drugs as of 2023)
Table 39. Date of Key Players Enter into siRNA Drugs Market
Table 40. Global siRNA Drugs Key Players Headquarters and Area Served
Table 41. siRNA Drugs Product Solution and Service
Table 42. Global siRNA Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Alnylam Basic Information List
Table 45. Alnylam Description and Business Overview
Table 46. Alnylam siRNA Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in siRNA Drugs Business of Alnylam (2018-2023)
Table 48. Alnylam Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis siRNA Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in siRNA Drugs Business of Novartis (2018-2023)
Table 53. Novartis Recent Developments
Table 54. Sirnaomics Basic Information List
Table 55. Sirnaomics Description and Business Overview
Table 56. Sirnaomics siRNA Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in siRNA Drugs Business of Sirnaomics (2018-2023)
Table 58. Sirnaomics Recent Developments
Table 59. Ribo Life Science Basic Information List
Table 60. Ribo Life Science Description and Business Overview
Table 61. Ribo Life Science siRNA Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in siRNA Drugs Business of Ribo Life Science (2018-2023)
Table 63. Ribo Life Science Recent Developments
Table 64. North America siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. North America siRNA Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 66. Europe siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 67. Europe siRNA Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 68. Asia-Pacific siRNA Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 69. Asia-Pacific siRNA Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 70. Asia-Pacific siRNA Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 71. Asia-Pacific siRNA Drugs Market Share by Region (2018-2023)
Table 72. Asia-Pacific siRNA Drugs Market Share by Region (2024-2033)
Table 73. Latin America siRNA Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 74. Latin America siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 75. Latin America siRNA Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 76. Middle East & Africa siRNA Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 77. Middle East & Africa siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 78. Middle East & Africa siRNA Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 79. siRNA Drugs Market Trends
Table 80. siRNA Drugs Market Drivers
Table 81. siRNA Drugs Market Challenges
Table 82. siRNA Drugs Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global siRNA Drugs Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global siRNA Drugs Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global siRNA Drugs Market Share by Regions: 2023 VS 2033
Figure 4. Global siRNA Drugs Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America siRNA Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe siRNA Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific siRNA Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America siRNA Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa siRNA Drugs Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Without GalNAc-conjugated
Figure 11. Global Without GalNAc-conjugated Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of With GalNAc-conjugated
Figure 13. Global With GalNAc-conjugated Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global siRNA Drugs Market Size Share by Type: 2023 & 2033
Figure 15. North America siRNA Drugs Revenue Market Share by Type (2018-2033)
Figure 16. Europe siRNA Drugs Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific siRNA Drugs Revenue Market Share by Type (2018-2033)
Figure 18. Latin America siRNA Drugs Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa siRNA Drugs Revenue Market Share by Type (2018-2033)
Figure 20. Genetic Disease Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Cancers Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global siRNA Drugs Market Size Share by Application: 2023 & 2033
Figure 24. North America siRNA Drugs Revenue Market Share by Application (2018-2033)
Figure 25. Europe siRNA Drugs Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific siRNA Drugs Revenue Market Share by Application (2018-2033)
Figure 27. Latin America siRNA Drugs Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa siRNA Drugs Revenue Market Share by Application (2018-2033)
Figure 29. siRNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 30. Global Top 5 and Top 10 Players siRNA Drugs Market Share in 2023
Figure 31. North America siRNA Drugs Market Share by Country (2018-2033)
Figure 32. United States siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 33. Canada siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 34. Germany siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 35. France siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 37. Italy siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 38. Russia siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific siRNA Drugs Market Share by Region (2018-2033)
Figure 41. China siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 42. Japan siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 45. India siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 46. Australia siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America siRNA Drugs Market Share by Country (2018-2033)
Figure 48. Mexico siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa siRNA Drugs Market Share by Country (2018-2033)
Figure 51. Turkey siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 53. UAE siRNA Drugs Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report